COMMUNIQUÉS West-GlobeNewswire

B-Temia et Wistron annoncent la création de B-Temia Asia

28/11/2018 - 08:00

B-Temia Asia lancera le Keeogo(TM), son appareil de mobilité humaine sur le marché asiatique QUÉBEC, 28 nov. 2018 (GLOBE NEWSWIRE) -- B-Temia Inc. a annoncé aujourd’hui la création officielle de B-Temia Asia Pte. Ltd., [...]

ObsEva SA Announces Initiation of Phase 3 IMPLANT 4 Trial of Nolasiban in Europe, Canada and Russia for Improving IVF Outcomes

28/11/2018 - 07:00

Geneva, Switzerland and Boston, MA – November 28, 2018 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for [...]

B-Temia and Wistron Announce the Incorporation of B-Temia Asia

28/11/2018 - 02:00

B-Temia Asia will launch human mobility device Keeogo(TM) in the Asia Market QUÉBEC CITY, Nov. 27, 2018 (GLOBE NEWSWIRE) -- B-Temia Inc. today announced the official incorporation of B-Temia Asia Pte. Ltd., as a result [...]

B-Temia et Wistron annoncent la création de B-Temia Asia

28/11/2018 - 02:00

B-Temia Asia lancera le Keeogo(TM), son appareil de mobilité humaine sur le marché asiatique QUÉBEC, 27 nov. 2018 (GLOBE NEWSWIRE) -- B-Temia Inc. a annoncé aujourd’hui la création officielle de B-Temia Asia Pte. Ltd., [...]

Abattis Comments on BCSC Temporary Order

28/11/2018 - 00:45

VANCOUVER, British Columbia, Nov. 27, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp (the “ Company ” or “ Abattis ”) (CSE:ATT) (OTC:ATTBF) comments on the news release regarding the British Columbia Securities [...]

Coherus BioSciences Announces New Employment Inducement Grants

28/11/2018 - 00:00

REDWOOD CITY, Calif., Nov. 27, 2018 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS), today announced that effective November 14, 2018, the compensation committee of the company’s board of directors granted [...]

Agility Health Announces Director Resignation

27/11/2018 - 23:43

Not for distribution to United States Newswire Services or for dissemination in the United States HAMILTON, Ontario, Nov. 27, 2018 (GLOBE NEWSWIRE) -- Agility Health, Inc. (TSXV: AHI) (“Agility Health” or, the “Company [...]

MacroGenics Announces Participation in Three Investor Conferences

27/11/2018 - 22:30

ROCKVILLE, MD, Nov. 27, 2018 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for [...]

ContraVir Pharmaceuticals to Present CRV431 Preclinical Data at the Anti-Fibrotic Drug Development Summit

27/11/2018 - 22:30

EDISON, N.J., Nov. 27, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical company focused on the development and commercialization of therapeutic drugs for the treatment of liver [...]

Galapagos receives Fast Track designation from FDA for GLPG1972/S201086 in osteoarthritis

27/11/2018 - 22:23

Mechelen, Belgium; 27 November 2018, 22.01 CET - Galapagos NV (Euronext & NASDAQ: GLPG) announced today that the FDA has granted GLPG1972/S201086 Fast Track designation for the treatment of patients with [...]

Acura Pharmaceuticals Announces Third Quarter 2018 Financial Results

27/11/2018 - 22:15

PALATINE, Ill., Nov. 27, 2018 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB: ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, announced today financial results for the three and nine [...]

Catalyst Pharmaceuticals Announces Firdapse® (amifampridine) New Drug Application Continues Under Review

27/11/2018 - 22:12

FDA PDUFA goal date remains tomorrow, November 28, 2018 CORAL GABLES, Fla., Nov. 27, 2018 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals Inc. (Nasdaq:CPRX) today reports that no decision has yet been received from the [...]

Representatives of Fulgent Genetics to Participate in the Piper Jaffray 30th Annual Healthcare Conference

27/11/2018 - 22:05

TEMPLE CITY, Calif., Nov. 27, 2018 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”) today announced that its Chairman and Chief Executive Officer Ming Hsieh and its Chief [...]

EyePoint Pharmaceuticals Appoints Ron Honig, Esq., as SVP, General Counsel & Company Secretary

27/11/2018 - 22:05

- Industry veteran who brings over 25 years of legal expertise in the medical device industry to newly created position - WATERTOWN, Mass., Nov. 27, 2018 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT [...]

Assure Holdings Reports Third Quarter 2018 Financial Results

27/11/2018 - 22:05

Revenue Increased 57% to $6.1 Million on Managed Case Growth of 90% DENVER, Nov. 27, 2018 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative [...]

CORRECTION: Psoria-Shield, Inc. and Neo Phototherapy LLC Developing Next Generation LED Phototherapy Device

27/11/2018 - 22:01

HOFFMAN ESTATES, IL, Nov. 27, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Wellness Center USA, Inc. (OTCQB: WCUI ) and Psoria-Shield, Inc. (PSI) today announced the formation of a Joint Venture between Psoria-Shield, [...]

GW Pharmaceuticals plc Reports Fiscal Fourth Quarter and Year-End 2018 Financial Results and Operational Progress

27/11/2018 - 22:00

- Epidiolex ® (cannabidiol) oral solution (CV), first FDA-approved plant-derived cannabinoid medicine launched in the U.S. - - Conference call today at 4:30 p.m. EST - LONDON and CARLSBAD, Calif., Nov. 27, 2018 (GLOBE [...]

Stryker announces pricing of €2.25 billion senior notes offering

27/11/2018 - 21:06

Kalamazoo, Michigan, Nov. 27, 2018 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced today that it has priced the following notes: (i) €550 million aggregate principal amount of the Company’s 1.125% Notes due 2023 (the “ [...]

Theratechnologies’ CFO to Present at 30th Annual Piper Jaffray and at BMO Healthcare Conferences

27/11/2018 - 19:25

MONTREAL, Nov. 27, 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) is pleased to announce that Philippe Dubuc, Senior Vice President and Chief Financial Officer will present at the 30 th [...]